Title: Low LATS2 expression is associated with poor prognosis in non-small cell lung carcinoma
Abstract: ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Jang S, Oh M, Cho HD, et al. Low LATS2 expression is associated with poor prognosis in non-small cell lung carcinoma. Polish Journal of Pathology. 2019;70(3):189-197. doi:10.5114/pjp.2019.90395. APA Jang, S., Oh, M., Cho, H. D., Lee, J., Lee, H. J., & Ahn, H. et al. (2019). Low LATS2 expression is associated with poor prognosis in non-small cell lung carcinoma. Polish Journal of Pathology, 70(3), 189-197. https://doi.org/10.5114/pjp.2019.90395 Chicago Jang, Si-Hyong, Mee-Hye Oh, Hyun D Cho, Ji-Hye Lee, Hyun J Lee, Hyein Ahn, and Han J Kim. 2019. "Low LATS2 expression is associated with poor prognosis in non-small cell lung carcinoma". Polish Journal of Pathology 70 (3): 189-197. doi:10.5114/pjp.2019.90395. Harvard Jang, S., Oh, M., Cho, H., Lee, J., Lee, H., Ahn, H., and Kim, H. (2019). Low LATS2 expression is associated with poor prognosis in non-small cell lung carcinoma. Polish Journal of Pathology, 70(3), pp.189-197. https://doi.org/10.5114/pjp.2019.90395 MLA Jang, Si-Hyong et al. "Low LATS2 expression is associated with poor prognosis in non-small cell lung carcinoma." Polish Journal of Pathology, vol. 70, no. 3, 2019, pp. 189-197. doi:10.5114/pjp.2019.90395. Vancouver Jang S, Oh M, Cho H, Lee J, Lee H, Ahn H et al. Low LATS2 expression is associated with poor prognosis in non-small cell lung carcinoma. Polish Journal of Pathology. 2019;70(3):189-197. doi:10.5114/pjp.2019.90395.